A1. Why did the Alaska legislature form the Alaska Vaccine Assessment Program (AVAP)?
A2. How does the program save money?
A3. How does AVAP work for payers and providers?
A4. Who oversees the program?
A5. Are insurance carriers the only entities paying the assessment?
A6. What does "assessable entity" mean?
A7. Must both the employer and the insurer, or third-party administrator (TPA) administering the plan, pay the assessment for a given covered life?
No. AVAP avoids counting any covered life twice by holding the entity that pays for the vaccine administration cost also responsible for paying the assessment.
A8. Must Employee Retirement Income Security Act (ERISA) plans pay the assessment?
A9. Are publicly funded health care benefit plans mandated to participate in AVAP?
A10. How are an entity's assessments determined?
A11. What is the current assessment rate?
A12. Are the childhood and adult vaccine-eligible populations combined to form a single assessment cost per payer?
A13. Are payments made by assessment payers accountable as medical expenses?
A14. Does the Patient Protection and Affordable Care Act (ACA) preempt any provisions of the AVAP?
No. The ACA does not preempt any provision of state law unless a state law prevents the application of an ACA requirement. AVAP supports the ACA requirement that coverage be provided without the imposition of cost-sharing for immunizations for routine use in children and adults.
A15. Where can I find more details about the AVAP assessment rate calculation?
A16. When are assessment payments due?
A17. What if AVAP collects too little?
A18. What if AVAP collects too much?
A19. If I am a Payer, where do I go to complete the online assessment?
Click here for the online assessment. First-time users must register before they can log in to the assessment system. Please note that because of the system’s security features, there may be a delay of up to 30 minutes before a new account can be accessed for data entry.
A20. Are there any tutorials on the use of this system?
A21. What if I have registered in the assessment system, but I need to change some of my information?
Please email Help@AKvaccine.org with an explanation of what adjustments you need and provide your contact information. A trained representative will follow-up on your request.
A22. If I make a mistake in my report, how can I correct it?
A23. I accidentally overpaid. Can I be reimbursed?
Yes. Please e-mail Help@AKvaccine.org explaining the mistake and the amount you need for reimbursement. The AVAP Council will then determine the best way to correct the mistake.
A24. How do I submit my payment?
A25. What if I submit a late report or payment?
A26. How do I create a password for the assessment system on www.akvaccine.org?
A27. What should I do if my company has created a password for the assessment system on www.akvaccine.org, but I no longer have it?
A28. Can payers opt out of the Alaska Vaccine Assessment Program?
A29. Is the assessment voluntary?
A30. Will participating payers save money starting in 2016?
C1. Must entities report only child covered lives, or should adult covered lives be included as well?
C2. What are “adult covered lives”?
C3. What are “child covered lives”?
C4. Must an entity file reports even if it does not provide medical benefits and therefore has zero covered lives?
C5. If an entity files a Permanent Zero Covered Lives Report, but it later has covered lives, what should it do?
C6. If my company has filed an Annual Zero Covered Lives Report, when should we file our next report?
An Annual Zero Covered Lives Report covers one calendar year. You should plan to file your report again by February 15th of each calendar year.
G1. Has AVAP changed anything for the federally funded Vaccines for Children Program (VFC) or state-sponsored medical plans?
G2. Do providers still need to screen for VFC eligibility?
P1. Does this program affect how providers receive vaccine?
P2. What are the benefits for my practice in receiving state-supplied vaccine through AVAP?
AVAP is able to buy vaccines at discounted rates off a bulk contract compared to market prices. Providers can then receive state-supplied vaccines for all covered patients and avoid the financial and administrative burdens of purchasing vaccines and maintaining separate vaccine storage and tracking systems.
P3. Can providers still purchase vaccines privately?
P4. Do providers need to pay for state-supplied vaccines for children and covered adults?
P5. How does this program affect patients?
P6. Are health care providers who care for uninsured adults required to participate in the assessment?
P7. Could providers get vaccine for uninsured adults, funded by surplus funds, even if they don't opt in?
P8. Will providers incur a higher assessment cost for adult vaccines than they are currently paying?
P9. How will providers be compensated for the administration of vaccines?
P10. Are pharmacists able to participate in the program?
Yes. Pharmacists may also enroll in the Vaccine Distribution Program to receive state-supplied vaccine for all children and for adults who are covered by participating payers.
P11. Should providers bill $0.00 or $0.01 for state-supplied vaccines?
P12. How do providers enroll to receive state-supplied vaccine?
P13. How can I get updated information on AVAP?
P14. What patient eligibility (VFC) Codes should be used?
P15. Will providers have a choice of which vaccine brands to use?
V1. Who sets vaccine policy?
V2. What vaccines are covered by the Alaska Immunization Program?
V3. Is the cost of seasonal flu vaccine included in the assessment rates?
V4. Does AVAP establish a vaccine mandate?
V5. What is VacTrAK?
V6. Does AVAP impact my taxes?
No. AVAP does not impact taxes as it is not funded by taxpayers. AVAP collects the costs of vaccines and program expenses from insurers, third-party administrators, and other payers who are already obligated to pay health care costs for their beneficiaries.
V7. How does AVAP know the amount of vaccine it needs to purchase?
V8. Does DOH expect vaccine uptake rates to increase once AVAP goes into effect?
Yes. DOH expects vaccination rates for most childhood vaccines required in school to be stable or increase slightly as immunization rates in school-aged children are already over 90-95% for many vaccines. DOH expects a gradual increase over the next few years in uptake of some childhood vaccines used in infancy, such as rotavirus and PCV13. Additionally, DOH expects an increase in teen HPV vaccine uptake. Since AVAP will increase vaccine availability, DOH anticipates a gradual increase in some adult vaccines such as Zoster.